Republic Digital Acquisition Company (NASDAQ:RDAGU) has filed for a $220 million SPAC to hunt for a target in crypto and blockchain technology. The underwriter will be Cantor, which has priced two IPOs so far this year and has four more on file to IPO including Republic Digital. More
The crop of 13 SPAC sponsors and target companies coming loose from their lock-up agreements this month are representatives of some counter-narrative trends as the two best performing deals are Latin American companies on the eve of new tariffs and the lowest performers are those from the buzzy world of AI software applications. More
Helix II (NASDAQ:HLXB) has entered into a definitive agreement to combine with cancer drug developer BridgeBio at an enterprise value of $360 million. San Francisco-based BridgeBio is developing a trio of potential treatments specifically targeting the KRAS mutation in some lung, breast, pancreatic, and colon cancers. More
On a day that the market takes in more Core PCE inflation readings, SPAC watchers also have the chance to peruse the S-1 of yet another former SPAC target that is trying its luck at the traditional IPO path. More
Fifth Era Acquisition Corp. I (NASDAQ:FERAU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol "FERAU", Friday, February 28, 2025. More
NewHold Investment Corp. III (NASDAQ:NHICU) announced the pricing of its $175 million IPO and its units are expected to begin trading on the Nasdaq under the symbol "NHICU", Friday, February 28, 2025. More
Live Oak Acquisition Corp. V (NASDAQ:LOKVU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol "LOKVU", Friday, February 28, 2025. More
One more SPAC will join the 2025 party as Rithm (NYSE:RAC.U) priced its $200 million IPO overnight bringing the year's count to 13 new searching SPACs. More
Rithm Acquisition Corp. (NYSE:RAC.U) announced the pricing of its $200 million IPO and its units are expected to begin trading on the NYSE under the symbol "RAC.U", Thursday, February 27, 2025. More
The biotech sector has represented a significant portion of SPAC dealflow over the past five years, but signs are showing that it may take some previously unanticipated hits from the transition to the new US administration. More
